Dr. Amanda Caissie MD, PhD, FRCPC is Associate Professor and Head of Dalhousie University’s Department of Radiation Oncology (DRO). A native Maritimer, she returned to work in the Dalhousie DRO after completing medical school at Queen’s University 2007 and radiation oncology residency at the University of Toronto 2012. A McGill alumna who completed her PhD in 2005, Dr. Caissie’s current research interests focus on Patient Reported Outcomes and Big Data as radiotherapy quality improvement (QI) initiatives fostered through inter-disciplinary collaborations such as the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) consortium. She is co-founder/co-lead of the recently formed Canadian Artificial intelligence and big Data in Radiotherapy Alliance (CADRA). Her other contributions to national and international radiotherapy QI initiatives include Chair of the Canadian Association of Radiation Oncology (CARO) Quality and Standards Committee, committee member of the American Association of Physicists in Medicine (AAPM)’s Big Data Subcommittee and Canadian Partnership for Quality Radiotherapy (CPQR), as well as international liaison in the European Association of Radiation Oncology (ESTRO)’s Radiation Oncology Safety and Quality Committee (ROSQ). Through her Nova Scotia Health (NSH) roles as Innovator in Residence and Medical Director of the Cancer Care Program’s Oncology Transformation Project, Dr Caissie aims to align clinical and research priorities for digital health solutions across the continuum of cancer care and beyond.
Recent News
In recent news, Dr. Amanda Caissie was named the newest Innovator in Residence at the Nova Scotia Health Innovation Hub, with a focus on patient engagement, digital oncology and artificial intelligence. [https://www.nshealth.ca/news/dr-amanda-caissie-named-nova-scotia-health-innovation-hubs-newest-innovator-residence]